| Date Filed | Type | Description |
| 10/03/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 08/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Gifted 3,500,000 shares
@ $0 |
|
| 08/17/2023 |
SC 13D/A
| Morningside Venture Investments Ltd reports a 8.6% stake in Kezar Life Sciences, Inc. |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Garner Elizabeth (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Wallace Courtney (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
4
| Klearman Micki (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/16/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 05/11/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/14/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|